HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer

Anticancer Research

Volumn 30, Issue 11, 2010, Pages 4779-4783

  Kamei, Mirei ^a   Yamashita, Shin Ichi ^a   Tokuishi, Keita ^a   Hashioto, Takafumi ^a   Moroga, Toshihiko ^a   Suehiro, Shuji ^a   Ono, Kiyoshi ^a   Miyawaki, Michiyo ^a   Takeno, Shinsuke ^a   Yamamoto, Satoshi ^a   Kawahara, Katsunobu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Breast cancer; HE4; Metastasis; Prognostic factor; WFDC2

Indexed keywords

GENE PRODUCT; HUMAN EPIDIDYMIS 4 PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE-FREE SURVIVAL; EPIDIDYMAL SECRETORY PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 78650252899     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, and Cruz AB, Foster R, Gardner B, Lerner H, Margolese R, Poisson R, Shibata H and Volk H: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52: 1551-1557, 1983.
2. Sotiriou C and Pusztai L: Gene expression signatures in breast cancer. N Engl J Med 360: 790-800, 2009.
3. Bingle L, Singleton V and Bingle CD: The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms. Oncogene 21: 2768-2773, 2002.
4. Wiedow O, Schröder JM, Gregory H, Young JA and Christophers E: Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem 265: 14791-14795, 1990.
5. Thompson RC and Ohlsson K: Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 83: 6692-6696, 1986.
6. Galgano MT, Hampton GM and Frierson HF Jr.: Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol 19: 847-853, 2006.
7. Bingle L, Cross SS, High AS, Wallace WA, Rassl D, Yuan G, Hellstrom I, Campos MA and Bingle CD: WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respir Res 7: 61-70, 2006.
8. Drapkin R, von Horsten HH, Lin Y, Mok SC, Crum CP, Welch WR and Hecht JL: Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res 65: 2162-2169, 2005.
9. Scholler N, Crawford M, Sato A, Drescher CW, O'Briant KC, Kiviat N, Anderson GL and Urban N: Bead-based ELISA for validation of ovarian cancer early detection markers. Clin Cancer Res 12: 2117-2124, 2006.
10. Bouchard D, Morisset D, Bourbonnais Y and Tremblay GM: Proteins with whey-acidic-protein motifs and cancer. Lancet Oncol 7: 167-174, 2006.
11. Devoogdt N, Hassanzadeh Ghassabeh G, Zhang J, Brys L, De Baetselier P and Revets H: Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells. Proc Natl Acad Sci USA 100: 5778-5782, 2003.
12. Ryu B, Jones J, Blades NJ, Parmigiani G, Hollingsworth MA, Hruban RH and Kern SE: Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression Cancer Res 62: 819-826, 2002.
13. Zhu H, Lam DC, Han KC, Tin VP, Suen WS, Wang E, Lam WK, Cai WW, Chung LP and Wong MP: High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in breast cancer cell lines. Cancer Lett 245: 303-314, 2007.